This chapter describes the recommended routine for follow-up of drug
resistant cases during treatment. Directly observed treatment is absolutely
indispensable in patients with drug resistant tuberculosis to avoid the development of
further resistance due to inadequate adherence. Monthly evaluation should include
active search of side effects and adverse reactions through clinical and laboratory
studies. Bacteriological follow-up will consist of monthly sputum smears and cultures,
and after culture conversion, monthly sputum smears and bimonthly cultures.
Keywords: Hospitalized, Hemoptysis, Isolation, Monitoring, Out-patient, Promoter,
Respiratory distress, Risk.